This Panel took place at LSI Europe ‘25 Emerging Medtech Summit in London.
Industry leaders from Veranex, Solas Bioventures, Medtronic, and a former FDA official discuss strategic approaches to evidence planning that create effective regulatory pathways for medical technologies.
This Panel featured:
Joseph Ferrara — Veranex
Laurent Pacheco — Solas Bioventures
Bill Niland — ReGelTec
Erin McEachren — Medtronic
Pablo Morales — Morales MedTech Advisors
Shai Ran Sapir — Mayo Clinic
Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits
Follow us on social:
LinkedIn: https://www.linkedin.com/company/life-science-intelligence/
Twitter: https://twitter.com/lsintelligence
Instagram: https://www.instagram.com/lifescienceintelligence/
Facebook: https://www.facebook.com/LifeScienceIntelligence/
Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09
Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw